AzTrials
AzTrials

HabituationNCT03237650

Conditioned Pain Modulation Using Painful Cutaneous Electrical Stimulation or Simply Habituation?

An observational study of Habituation, run by Ruhr University of Bochum.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Painful cutaneous electrical stimulation (PCES) and corresponding evoked potentials led to a significant pain relief and decrease of evoked potentials and has been used to analyze conditioned pain modulation (CPM). Read more about this study

Who is it for?
Ages 20 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Habituation
How many people
33 participants
Where
No sites listed yet
Study dates
Apr 2016to Sep 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: healthy subjects

Who may be able to join

  • healthy volunteers

Who cannot join

  • any kind of disease

About this study

Painful cutaneous electrical stimulation (PCES) and corresponding evoked potentials led to a significant pain relief and decrease of evoked potentials and has been used to analyze conditioned pain modulation (CPM). However, it is unknown whether the pain relief results from habituation to the repeated painful electric stimulation. We compared the effects of CPM and habituation on PCES-induced pain and PCES-evoked potentials and analyzed whether increased attention by a random change of electric intensities amplifies the habituation effects.

Conditions
Habituation
Keywords
Painful cutaneous electrical stimulation, Conditioned Pain Modulation
Medical subject headings
Substance-Related Disorders

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain relief

    pain intensity of painful cutaneous electrical stimulation on a numeric rating scale (NRS 0-100)

    Measured: during the measurement

  2. N1P1-amplitude

    Amplitudes of painful cutaneous electrical stimulation evoked potentials in µV

    Measured: during the measurement

Secondary outcomes (2)
  1. N1-latency

    Latency of the peak N1 of painful cutaneous electrical stimulation evoked potentials in msec

    Measured: during the measurement

  2. P0N1-amplitude

    Amplitudes of painful cutaneous electrical stimulation evoked potentials in µV

    Measured: during the measurement

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2017
  2. Study startApr 2016
  3. Primary completionSep 2016
  4. Study completionSep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case crossover
Time perspective
Cross-sectional
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03237650
Sponsor's protocol ID
PCES-Hab
Status last verified
Jul 2017
First submitted
30 Jul 2017
Last updated
2 Aug 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Habituation, run by Ruhr University of Bochum.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain relief (time frame: during the measurement). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in